Do endogenous ligands of peripheral μ- and δ-opiate receptors mediate antiarrhythmic and cardioprotective effects of Rhodiola rosea?

L. N. Maslov, Yu B. Lishmanov, A. V. Naumova, T. V. Lasukova

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Oral administration of Rhodiola rosea extract to rats (3.5 ml/kg, 8 days) prevents reperfusion arrhythmias and elicits a protective effect in experiments on isolated heart. Experiments with naloxone and ICI 174,864 suggest that the antiarrhythmic effect of R. rosea extract is mediated through activation of μ-opiate receptors in the myocardium. The cardioprotective effect of this extract is not associated with opiate receptors.

Original languageEnglish
Pages (from-to)754-756
Number of pages3
JournalBulletin of Experimental Biology and Medicine
Volume124
Issue number2
DOIs
Publication statusPublished - Aug 1997

Fingerprint

Rhodiola
Opioid Receptors
Ligands
Naloxone
Reperfusion
Oral Administration
Rats
Cardiac Arrhythmias
Myocardium
Experiments
Chemical activation

Keywords

  • μ-and δ-opiate receptors
  • adaptogens
  • arrhythmias
  • isolated heart

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Do endogenous ligands of peripheral μ- and δ-opiate receptors mediate antiarrhythmic and cardioprotective effects of Rhodiola rosea? / Maslov, L. N.; Lishmanov, Yu B.; Naumova, A. V.; Lasukova, T. V.

In: Bulletin of Experimental Biology and Medicine, Vol. 124, No. 2, 08.1997, p. 754-756.

Research output: Contribution to journalArticle

@article{3a20cc992b09494d854029d3f7f143b9,
title = "Do endogenous ligands of peripheral μ- and δ-opiate receptors mediate antiarrhythmic and cardioprotective effects of Rhodiola rosea?",
abstract = "Oral administration of Rhodiola rosea extract to rats (3.5 ml/kg, 8 days) prevents reperfusion arrhythmias and elicits a protective effect in experiments on isolated heart. Experiments with naloxone and ICI 174,864 suggest that the antiarrhythmic effect of R. rosea extract is mediated through activation of μ-opiate receptors in the myocardium. The cardioprotective effect of this extract is not associated with opiate receptors.",
keywords = "μ-and δ-opiate receptors, adaptogens, arrhythmias, isolated heart",
author = "Maslov, {L. N.} and Lishmanov, {Yu B.} and Naumova, {A. V.} and Lasukova, {T. V.}",
year = "1997",
month = "8",
doi = "10.1007/BF02445082",
language = "English",
volume = "124",
pages = "754--756",
journal = "Bulletin of Experimental Biology and Medicine",
issn = "0007-4888",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Do endogenous ligands of peripheral μ- and δ-opiate receptors mediate antiarrhythmic and cardioprotective effects of Rhodiola rosea?

AU - Maslov, L. N.

AU - Lishmanov, Yu B.

AU - Naumova, A. V.

AU - Lasukova, T. V.

PY - 1997/8

Y1 - 1997/8

N2 - Oral administration of Rhodiola rosea extract to rats (3.5 ml/kg, 8 days) prevents reperfusion arrhythmias and elicits a protective effect in experiments on isolated heart. Experiments with naloxone and ICI 174,864 suggest that the antiarrhythmic effect of R. rosea extract is mediated through activation of μ-opiate receptors in the myocardium. The cardioprotective effect of this extract is not associated with opiate receptors.

AB - Oral administration of Rhodiola rosea extract to rats (3.5 ml/kg, 8 days) prevents reperfusion arrhythmias and elicits a protective effect in experiments on isolated heart. Experiments with naloxone and ICI 174,864 suggest that the antiarrhythmic effect of R. rosea extract is mediated through activation of μ-opiate receptors in the myocardium. The cardioprotective effect of this extract is not associated with opiate receptors.

KW - μ-and δ-opiate receptors

KW - adaptogens

KW - arrhythmias

KW - isolated heart

UR - http://www.scopus.com/inward/record.url?scp=26944434390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944434390&partnerID=8YFLogxK

U2 - 10.1007/BF02445082

DO - 10.1007/BF02445082

M3 - Article

AN - SCOPUS:26944434390

VL - 124

SP - 754

EP - 756

JO - Bulletin of Experimental Biology and Medicine

JF - Bulletin of Experimental Biology and Medicine

SN - 0007-4888

IS - 2

ER -